Henry A. Fernandez - 30 Jun 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Henry A. Fernandez
Issuer symbol
RPRX
Transactions as of
30 Jun 2025
Net transactions value
+$37,495
Form type
4
Filing time
30 Jun 2025, 17:06:05 UTC
Previous filing
14 May 2025
Next filing
28 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fernandez Henry A Director C/O ROYALTY PHARMA PLC, 110 E. 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact for Henry A. Fernandez 30 Jun 2025 0001416750

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $37,495 +1,064 +1.7% $35.24 65,324 30 Jun 2025 Direct F1
holding RPRX Class A Ordinary Shares 58,200 30 Jun 2025 By Fernandez 2007 Children's Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.